Phlow Corp.
5 private offerings reported to the SEC on Form D since 2016, $74.7M sold in all. Pharma, Virginia.
- Form D offerings: 5
- Reported sold: $74.7M
- Newest: Feb 14, 2025
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Feb 14, 2025 | — | $30.5M | $40.0M | Phlow Corp.Pharma · Virginia | Not amended | 0001832917-25-000001 |
| Jul 10, 2024 | — | $5.0M | $25.0M | Phlow Corp.Pharma · Virginia | Not amended | 0001832917-24-000001 |
| Sep 2, 2022 | — | $24.2M | $50.0M | Phlow Corp.Pharma · Virginia | Not amended | 0001832917-22-000001 |
| Nov 20, 2020 | — | $15.0M | $20.0M | Phlow Corp.Pharma · Virginia | Not amended | 0001567619-20-020116 |
| Nov 18, 2020 | — | None yet | $8.1M | Phlow Corp.Pharma · Virginia | Not amended | 0001567619-20-020055 |
- Business address
- Richmond, Va
- Incorporated in
- Delaware
- All SEC filings
- CIK 1832917 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR